Table 2.
Classification of responders after 3 weeks and at the end of treatment
| Treatment period | a) ImproWin®/ImproWin® (n = 36) | b) Placebo/ImproWin® (n = 11) | c) Placebo/Placebo (n = 31/n = 20) |
|---|---|---|---|
| 3 weeks |
25/36 |
0/11 |
18/31 |
| |
69.4 (51.9 – 83 .7) |
0.0 (0.0 – 28.5) |
58.1 (40.0 - 74.1) |
| End of treatment |
28/36 |
6/11 |
17/31 |
| 77.8 (60.9 – 89–9) | 54.6 (23.4 – 83.3) | 54.8 (34.7 – 73.0) |
Classification of responders after 3 weeks and at the end of treatment in the groups given a) Only ImproWin® b) Placebo and ImproWin® the last part and c) Only placebo. The results are expressed as number of responders and percent responders with 95% confidence interval.